Articles

The National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), recently awarded a $2.5 million grant to Mayo Clinic’s Cardiorenal Research Laboratory...

Cardiology physician groups and institutions are increasingly being challenged to effectively manage their ambulatory electrocardiography (AECG) and cardiovascular implantable electronic device (...

Hardware and software advances are enabling echocardiography to greatly expand its capability with increased quantification accuracy, ease-of-use, increased workflow efficiencies and wider use...

Methodist DeBakey Heart and Vascular Center in Houston, Tex., has leveraged new imaging and interventional technologies to help contain and reduce costs, increase patient volume and revenues and...

The American College of Cardiology (ACC) 2012 Scientific Session, held March 24-27 in Chicago, was the first major cardiology show this year for vendors to display their latest innovations. A...

Patients with the heart rhythm disorder atrial fibrillation (AFib) who received first-line catheter ablation treatment had a longer arrhythmia-free interval than patients receiving anti-...

 

A study of more than 350 competitive athletes with implantable cardioverter defibrillators (ICDs) from around the world showed for the first time that sports may be safer for this...

April 27, 2012 — GE Healthcare, a unit of General Electric Company, announced the U.S. Food and Drug Administration (FDA) clearance and availability of the latest version of its Vivid E9...

The gloves are off and the fight has begun between St. Jude Medical and Medtronic over clinical data regarding their ...

The U.S. Food and Drug Administration (FDA) approved an expanded indication for Medtronic’s cardiac resynchronization therapy with implantable cardioverter defibrillator (CRT-D) devices...